Vertex Pharmaceuticals Incorporated
IT ˙ BIT ˙ US92532F1003
366,30 € ↓ -1,30 (-0,35%)
2026-06-03
AKTIENPREIS
SecurityIT:1VRTX / Vertex Pharmaceuticals Incorporated
InstitutionInvesco Ltd.
Latest Disclosed Ownership2,561,057 shares
Latest Disclosed Value $ 1,143,614,420
Invesco Ltd. reports 18.97% increase in ownership of 1VRTX / Vertex Pharmaceuticals Incorporated

On May 12, 2026 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 2,561,057 shares of Vertex Pharmaceuticals Incorporated (IT:1VRTX) valued at $972,177,237 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 19, 2026 disclosing 2,152,672 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 18.97% during the quarter. The current value of the position is $938,115,179 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,561,057 408,385 18.97 1,143,614 17.18 0.1751
2026-02-19 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,152,672 55,875 2.66 975,935 18.84 0.1496
2025-11-13 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,096,797 112,751 5.68 821,189 -7.03 0.1294
2025-08-13 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,984,046 138,406 7.50 883,297 -1.29 0.1502
2025-05-12 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,845,640 -52,817 -2.78 894,803 17.04 0.1695
2025-02-13 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,898,457 -45,147 -2.32 764,509 -15.42 0.1413
2024-11-12 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,943,604 140,862 7.81 903,931 6.98 0.1745
2024-08-13 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,802,742 -288,401 -13.79 844,981 -3.33 0.1787
2024-05-14 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,091,143 -150,964 -6.73 874,119 -4.18 0.1878
2024-02-13 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,242,107 225,327 11.17 912,291 30.08 0.2171
2023-11-13 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,016,780 67,451 3.46 701,315 2.23 0.1889
2023-08-11 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,949,329 87,961 4.73 685,988 16.97 0.1798
2023-05-12 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,861,368 236,469 14.55 586,461 24.98 0.1636
2023-02-13 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,624,899 305,217 23.13 469,238 22.81 0.1374
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,319,682 196,888 17.54 382,097 20.77 0.1230
2022-08-15 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,122,794 -87,563 -7.23 316,393 0.17 0.0959
2022-05-16 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,210,357 88,199 7.86 315,867 28.18 0.0806
2022-02-14 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,122,158 -92,335 -7.60 246,426 11.86 0.0594
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,214,493 48,410 4.15 220,294 -6.30 0.0558
2021-08-17 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,166,083 197,494 20.39 235,117 12.96 0.0578
2021-05-17 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 968,589 -129,332 -11.78 208,141 -19.79 0.0555
2021-02-16 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,097,921 -33,046 -2.92 259,482 -15.69 0.0755
2020-11-16 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,130,967 11,258 1.01 307,760 -5.32 0.1040
2020-08-14 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,119,709 -182,032 -13.98 325,064 4.94 0.1162
2020-05-15 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,301,741 207,470 18.96 309,749 29.28 0.1304
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,094,271 -2,565,660 -70.10 239,590 -61.36 0.0744
2019-11-14 2019-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,659,931 -403,977 -9.94 620,066 -16.80 0.1622
2019-08-14 2019-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 4,063,908 335,938 9.01 745,238 8.67 0.1918
2019-08-14 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 4,063,908 -3,614,031 745,238
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,727,970 21,753 0.59 685,762 11.66 0.2313
2019-02-14 2018-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,706,217 -11,713 -0.32 614,157 -14.29 0.2351
2018-11-14 2018-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,717,930 -77,449 -2.04 716,593 11.09 0.2255
2018-08-14 2018-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,795,379 515,949 15.73 645,063 20.69 0.2135
2018-05-15 2018-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,279,430 169,936 5.47 534,481 14.70 0.1998
2018-02-14 2017-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,109,494 14,479 0.47 465,987 -0.97 0.1680
2017-11-14 2017-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,095,015 -166,710 -5.11 470,564 11.95 0.1738
2017-08-14 2017-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,261,725 328,399 11.20 420,339 31.05 0.1308
2017-05-15 2017-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,933,326 29,887 1.03 320,758 49.96 0.1053
2017-02-14 2016-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,903,439 -163,512 -5.33 213,898 -20.03 0.0719
2016-11-14 2016-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,066,951 -105 -0.00 267,470 1.38 0.0919
2016-08-15 2016-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,067,056 -258,054 -7.76 263,828 -0.18 0.0969
2016-05-16 2016-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,325,110 -926,098 -21.78 264,314 -50.59 0.1074
2016-02-16 2015-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 4,251,208 164,266 4.02 534,929 25.68 0.2134
2015-11-16 2015-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 4,086,942 334,402 8.91 425,614 -8.15 0.1806
2015-08-14 2015-06-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 3,752,540 233,736 6.64 463,366 11.62 0.1818
2015-05-15 2015-03-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 3,518,804 432,823 14.03 415,114 13.23 0.1606
2015-02-13 2014-12-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 3,085,981 234,511 8.22 366,615 14.48 0.1416
2014-11-14 2014-09-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 2,851,470 -153,621 -5.11 320,249 12.56 0.1279
2014-08-14 2014-06-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 3,005,091 -157,853 -4.99 284,521 27.20 0.1119
2014-05-15 2014-03-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 3,162,944 -94,408 -2.90 223,683 -7.58 0.0907
2014-02-13 2013-12-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 3,257,352 156,515 5.05 242,022 2.94 0.0961
2013-11-13 2013-09-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 3,100,837 231,466 8.07 235,106 2.34 0.1022
2013-08-14 2013-06-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 2,869,371 2,869,371 229,721 0.1071
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.